Delivery Order SPE2DB22D3016-SPE2DB26FAAX8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,020.48 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution in 50ml units. This firm fixed-price delivery order, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution in 4ML vials, with a ceiling value of $1,806.12. This firm fixed-price delivery order, issued on August 27, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract is scheduled for ultimate completion by...
- The Defense Logistics Agency awarded a delivery order valued at $1,010.94 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lidocaine HCL 4% Solution in 4ML vials, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution 4ML on June 10, 2025, with a ceiling value of $1,209.14 and ultimate completion date of June 11, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution in 50mL quantities, with a contract value of $1,076.48. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The U.S. Defense Logistics Agency (DLA) awarded a $22,692.39 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the provision of 4% Lidocaine HCL Solution (4 ml). The contract has an ultimate completion date of May 4, 2023. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office division in Conshohocken, Pennsylvania. The $1,623.22 order is for the supply of Lidocaine HCL 4% Solution in 4 mL vials. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,809.06 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 50ML (25 units) with an ultimate completion date of September 29, 2025. This competitive award, issued on September 2, 2025, carries firm fixed pricing and involves no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 2% 40 mg/2 mL vials on August 14, 2025, with a ceiling value of $9,369.36 and firm fixed pricing. This non-set-aside, competitively awarded contract is classified as a delivery order with an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform under this award at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,437.99 to AmerisourceBergen Drug Corp for Lidocaine HCL 1% vials (10 mL) on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes firm fixed pricing with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FAAX8Delivery Order
The Defense Logistics Agency has awarded a delivery order valued at $21,493.87 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution in 4ml units. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by October 31, 2025. The award was issued on October 30, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.5k | 10/30/25 |